# Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD

> **NCT02720198** · PHASE3 · COMPLETED · sponsor: **Duke University** · enrollment: 60 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Levomilnacipran
- **DRUG:** Quetiapine

## Key facts

- **NCT ID:** NCT02720198
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-23
- **Primary completion:** 2018-06-12
- **Final completion:** 2018-06-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-08-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02720198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02720198, "Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02720198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*